Willis-Knighton Health System has been named a Screening Center of Excellence by the GO2 Foundation for Lung Cancer for its ongoing commitment to responsible lung cancer screening. Low dose CT screening for lung cancer carried out safely, efficiently and equitably can save tens of thousands of lives a year by finding lung cancer early when it is most treatable and even curable.
“We are thrilled to be part of this elite group, setting an example for responsible screening practices across the country,” says Vincent Sedminik, director of the Willis-Knighton Cancer Center. “Willis-Knighton Health System provides patients with the highest quality care. Low dose CT screening has shown to be the only proven method to detect lung cancer at an early and treatable stage.”
“We are proud and honored to be working with Willis-Knighton Health System as a GO2 Foundation for Lung Cancer Screening Center of Excellence,” says Laurie Fenton Ambrose, GO2 Foundation co-founder, president and CEO. “Their commitment to practice responsible lung cancer screening will lead to advancements in research and many lives saved. They are an example to follow.”
Designated Screening Centers of Excellence are committed to provide clear information on who is a candidate for lung cancer screening based on current evidence and to comply with comprehensive standards reflecting best practices developed by professional bodies such as the American College of Radiology (ACR), the National Comprehensive Cancer Network (NCCN) and the International Early Lung Cancer Action Program (I-ELCAP). Through established guidelines for controlling screening quality, radiation dose and diagnostic procedures within an experienced, multi-disciplinary clinical setting, Screening Centers of Excellence are ensuring that lung cancer screening’s life-saving benefit transforms lung cancer care in their local community.
